KMDA Kamada
Company Analysis
Latest News
🟢 Kamada is trading 5.39% up on November 6, 2026, as U.S. stocks rebounded after sell-off
Kamada is trading at $7.25, up 5.39%, in a move that appears consistent with broader risk-on sentiment as U.S. stocks rebounded after the previous session’s...
🔴 Kamada is trading 5.9% down with no clear company-specific catalyst identified
Kamada is trading at $6.98, down 5.93%, with no clear company-specific catalyst identified for the November 5 decline. - Kamada’s next earnings release is...
🔴 Kamada is trading 5.5% down in pre-market with no clear catalyst identified
Kamada is trading at $7.01, down 5.5%, with no clear reason identified for the November 5 pre-market decline. - No clear company-specific announcement...
🔴 Kamada is trading 5% down
Kamada is trading 5.06% down at $7.31, with no clear directly linked catalyst identified; the cause remains unclear. - The broader market is rising, so...
Rabies Surge Sends Kamada Shares to New Heights — But Can a Public Health Scare Sustain a 56% Gap to the Price Target?
Shares of Kamada Ltd. surged 8.7% to $9.62 as investors bet that a genuine U.S. public health crisis could translate into durable revenue upside for a $500...
🟢 Kamada is trading 8.7% up in pre-market on stronger U.S. rabies-treatment demand
Kamada is trading 8.7% up now at $9.62 as investors respond to increased U.S. rabies-treatment demand and the company’s confirmation of sufficient KedRAB...
🟢 Kamada is trading 5.7% up today after confirming sufficient KedRAB inventory and manufacturing capacity
Kamada is trading 5.7% up at $8.65 after confirming sufficient KedRAB inventory and manufacturing capacity amid increased U.S. demand. - The update followed a...
🟢 Kamada is trading 5.4% up today, possibly ahead of H.C. Wainwright presentation
Kamada is trading at $8.35, up 5.43%, possibly reflecting investor positioning ahead of CEO Amir London’s scheduled September 15 presentation at the H.C....